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Unusually this US study took a set of patients who had generally already initiated 
abstinence from cocaine use and then used abstinence incentives and/or cognitive-
behavioural therapy to extend and consolidate these gains. There was some evidence 
that offering the therapy and improving attendance via incentives prolonged the impact 
of those incentives.
Summary This US study of treatment for cocaine dependence aimed to test whether the 
remission of patients who had initially done well in intensive outpatient treatment could 
be preserved and extended by financially rewarding cocaine non-use ('contingency 
management') and/or by extra individual counselling sessions based on cognitive-
behavioural principles intended to help the patients avoid relapse. Unusually it tested 
contingency management not as way to initiate abstinence, but to sustain it. Essentially 
the study found that the combination of both approaches helped the greatest proportions 
of patients to remain free of cocaine use, most notably in the middle of the 18-month 
follow-up.
The study recruited 100 adult patients who had attended regularly during their initial 
fortnight at one of two 12-step group-based programmes. For up to four months, these 
programmes scheduled sessions three days a week totalling nine to 10 hours per week, 
before stepping down to a session a week. Of the 573 patients approached to see if they 
were suitable for and wanted to join the study, 200 did not join because they did not 
complete the initial fortnight or the following baseline research assessments. Among 
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other criteria, the patients had to have not injected heroin for at least a year. Typically 
participants were unmarried black women (nearly 6 in 10 were female) and were in the 
their late 30s and early 40s. By the time they entered the study, 70% had not used 
cocaine for at least a month.
They were randomly allocated to carry on with treatment as usual or to one of three 
additional therapies. For 12 weeks one set (the contingency management set) were 
rewarded with shopping vouchers if urine tests taken three days a week were clear of 
indications of cocaine use, a regimen implemented by non-clinical study staff. Another 
set (relapse-prevention patients) were instead offered 20 weekly individual relapse-
prevention counselling sessions aimed at identifying situations which for them had 
precipitated substance use and learning to anticipate and cope with these in future. The 
final set (combination patients) were offered both types of additional intervention, with 
the rider that the voucher incentives required not just cocaine-free urine tests, but also 
attendance at the relapse-prevention sessions. This seems to have had the desired 
impact, as on average they attended 13 sessions compared to just three for the relapse-
prevention patients who had been offered the same sessions but with no inducements to 
attend. By the final follow-up 18 months after the study started, three quarters of the 
patients could be reassessed by being interviewed and the same proportion by urine tests.
Main findings
Generally at each quarterly assessment from three months to 18 months after study start 
and on both the urine test and interview indicators, a smaller proportion of combination 
than of the other patients were found or assumed to have used cocaine. Only at the six-
month and nine-month points were these differences large and consistent enough to be 
statistically significant, in comparison specifically to the treatment-as-usual and relapse-
prevention patients. At no point did the non-combination patients allocated only to 
contingency management or only to relapse prevention sessions do significantly better 
than treatment-as-usual patients. This picture remained similar when all missed urine 
tests were assumed to be indicative of cocaine use rather than just those missed before 
the patient had entirely dropped out of treatment.
The authors' conclusions
The findings show that cocaine-dependent patients who have achieved initial engagement 
in an intensive outpatient programme and significant reductions in cocaine use can still 
benefit from incentives for cocaine-free urines. Reduced cocaine use was sustained for six 
months after incentives ended and was particularly strong when incentives were 
combined with individual cognitive-behavioural relapse-prevention sessions, as long as 
the incentives were also tied to consistent participation in the sessions. Without this 
'carrot', the patients apparently had little interest in adding the sessions to the required 
core programme. Since so few were attended, it is no surprise that offering these 
sessions did not improve on treatment as usual. When attendance was improved via 
incentives, the sessions did seem to make a positive difference, and the combination's 
benefits outlasted provision of both incentives and the sessions.
These persisting effects may have been due to the incentives helping to open up 
'windows of abstinence' (known to have happened from in-treatment urine tests) during 
which patients were exposed to 'natural' incentives for abstinence such as being able to 
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take up a new hobby, reconnect with non-drug-related friends, or other rewarding 
activities incompatible with a return to cocaine use. However, such windows were also 
opened by contingency management alone yet did not persist as well without relapse 
prevention sessions, suggesting that attending these sessions was the active ingredient 
in persisting cocaine use reductions. As intended, they may have equipped patients with 
better coping skills or greater self-efficacy and commitment to abstinence, and did 
provide the patients' sole opportunity to develop an individual relationship with a helpful 
and concerned therapist.
A puzzling finding was that offering relapse-prevention sessions without incentives 
actually seemed at most time points to make abstinence slightly (and non-significantly) 
less likely than not offering these sessions. Possibly relevant is that these patients 
attended significantly fewer of the core programme's therapy groups than the other 
patients (25 v. 38). Relapse prevention session were not fully integrated in to this core 
programme and were provided by different counsellors; perhaps offering them in some 
way confused the patients or undermined their motivation to continue in the core 
programme. 
 As the authors comment, a more usual strategy is to use incentives to 
initiate abstinence, paired with cognitive-behavioural therapy or therapies based on 
harnessing social networks to help sustain abstinence by teaching enduring skills, 
changing thought patterns, and altering how the user's social circle responds to them. In 
this guise there is research support for the combination. The featured study instead took 
a set of patients who had generally already initiated abstinence from cocaine use and 
sustained it for several weeks, and then used incentives and/or cognitive-behavioural 
therapy to extend and consolidate these gains. There was some evidence that this 
worked, specifically for the proposition that offering relapse prevention sessions and 
making attendance at these a requirement for incentives prolonged the impact of those 
incentives.
For methodological reasons (see below) these findings are suggestive only, but assuming 
they represent a real effect, forming a relationship with an experienced therapist may 
have been influential, though the average of 13 weekly sessions attended by the 
combination patients was just over the 12 weeks it would have taken to qualify for all the 
incentives. If these periods were concurrent, it seems possible that once attending the 
sessions was no longer incentivised, many contingency management patients stopped 
attending, not indicative of a strong relationship. However, some also continued, perhaps 
enough to make a small difference, and before leaving others may have absorbed the 
skills they later used to stay clear of cocaine.
Had (as is often the case) only the patient's own accounts of their cocaine use been available, except for nine-
month follow-up it would not have been possible to suggest that the relapse prevention sessions had helped 
preserve life changes patients made during abstinence windows opened up by incentives; the proportions 
abstinent were virtually identical whether or not incentives had been supplemented by the sessions. On this 
measure too, at the longest terms investigated by the study (15 and 18 months) it seems virtually nothing had 
been gained from adding any of the three options to usual treatment.
In respect of urine tests the gap between incentives plus sessions and incentives alone was also apparent at the 
six-month follow-up but had slipped back to near zero by a year and then remained under 10%. At this degree 
of difference the impact of missed interviews and tests becomes potentially important (by the end a quarter 
were missing), and generally more urines tests were missed than interviews.
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Another factor to consider is the possible demoralisation of patients who volunteered for the study perhaps on 
the 50-50 chance that they would stand to gain hundreds of dollars from doing what they hoped to do in any 
event, avoid using cocaine. Those who missed out will have seen their fellow patients (possibly in the same 
therapy groups) being rewarded for abstinence while they got nothing material out of their achievements.
Thanks for their comments on this entry in draft to James R. McKay of the University of Pennsylvania in the 
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